Hans Denison
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Helicobacter pylori-related gastroenterology studies, Antiplatelet Therapy and Cardiovascular Diseases, Eosinophilic Esophagitis, Acute Ischemic Stroke Management
Most-Cited Works
- → Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA(2020)576 cited
- → Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack(2016)525 cited
- → Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial(2017)196 cited
- → Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease(2010)108 cited
- → A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease(2008)108 cited
- → Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux Disease(2012)105 cited
- → A Randomized, Comparative Study of Three Doses of AZD0865 and Esomeprazole for Healing of Reflux Esophagitis(2007)103 cited
- → Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial(2013)102 cited
- → Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin(2020)98 cited
- → A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial(2011)81 cited